What does Dokter J.SONCK Cardiologie do?

Dokter J.SONCK Cardiologie is a specialist medical practice in Wemmel. Private Limited, started on 6 November 2001, 1 establishment.

What is the address of Dokter J.SONCK Cardiologie?

The registered office of Dokter J.SONCK Cardiologie is located at Leeuwerikenlaan 10, 1780 Wemmel.

Is Dokter J.SONCK Cardiologie still active?

Yes. According to the CBE (15 September 2026) Dokter J.SONCK Cardiologie is active, legal situation “Normale toestand”, started on 6 November 2001.

Is Dokter J.SONCK Cardiologie registered on Peppol?

Yes, Dokter J.SONCK Cardiologie is registered on the Peppol network with ID 0208:0476008692.

What is the enterprise number of Dokter J.SONCK Cardiologie?

The enterprise number of Dokter J.SONCK Cardiologie is BE0476008692.

When was Dokter J.SONCK Cardiologie founded?

Dokter J.SONCK Cardiologie was founded on 6 November 2001.

Who are the directors of Dokter J.SONCK Cardiologie?

According to the 2025 annual accounts, the directors of Dokter J.SONCK Cardiologie are: Jeroen Sonck.

Is Dokter J.SONCK Cardiologie a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 November 2001; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dokter J.SONCK Cardiologie make in 2025?

Dokter J.SONCK Cardiologie posted a profit after taxes of € 253,307 in financial year 2025.

What is the revenue of Dokter J.SONCK Cardiologie?

As a small company, Dokter J.SONCK Cardiologie is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 359,798.

Dokter J.SONCK Cardiologie (Private Limited) - Wemmel

Dossier Dokter J.SONCK Cardiologie, printed on 15 September 2026 from databakkes.be/en/0476008692/dokter-j-sonck-cardiologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dokter J.SONCK Cardiologie from Wemmel, company number BE0476008692, closed financial year 2025 with a result of € 253,307 after tax. For that financial year Dokter J.SONCK Cardiologie recorded a gross margin of € 359,798 and equity of € 1 million. Compared with financial year 2024, the result moved from € 306,787 to € 253,307. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 30, 2026.

What it is worth Growing

€ 1 million

▲ 8% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 253,307

▼ 17% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 863,530

▲ € 651,584 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 175,000 paid out

69 % of the profit went to the shareholders, the rest stayed in the company.

Debts at end 2025

Bank debt

€ 41,270

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 3,640

▼ 70% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 96,713

▲ 36% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 110,791 Gross margin 2022: € 110,791 First fiscal year in the series	€ 347,176 Gross margin 2023: € 347,176 ▲ 213% vs 2022 (€ 110,791) Favourable step	€ 408,989 Gross margin 2024: € 408,989 ▲ 18% vs 2023 (€ 347,176) Favourable step	€ 359,798 Gross margin 2025: € 359,798 ▼ 12% vs 2024 (€ 408,989) Unfavourable step	▼ 12%
Profit after taxes	€ 73,922 Profit after taxes 2022: € 73,922 First fiscal year in the series	€ 219,333 Profit after taxes 2023: € 219,333 ▲ 197% vs 2022 (€ 73,922) Favourable step	€ 306,787 Profit after taxes 2024: € 306,787 ▲ 40% vs 2023 (€ 219,333) Favourable step	€ 253,307 Profit after taxes 2025: € 253,307 ▼ 17% vs 2024 (€ 306,787) Unfavourable step	▼ 17%
Equity	€ 548,707 Equity 2022: € 548,707 First fiscal year in the series	€ 738,039 Equity 2023: € 738,039 ▲ 35% vs 2022 (€ 548,707) Favourable step	€ 954,826 Equity 2024: € 954,826 ▲ 29% vs 2023 (€ 738,039) Favourable step	€ 1,033,133 Equity 2025: € 1,033,133 ▲ 8% vs 2024 (€ 954,826) Favourable step	▲ 8%
Total debts	€ 75,675 Total debts 2022: € 75,675 First fiscal year in the series	€ 111,758 Total debts 2023: € 111,758 ▲ 48% vs 2022 (€ 75,675) Unfavourable step	€ 210,060 Total debts 2024: € 210,060 ▲ 88% vs 2023 (€ 111,758) Unfavourable step	€ 306,597 Total debts 2025: € 306,597 ▲ 46% vs 2024 (€ 210,060) Unfavourable step	▲ 46%
Cash	€ 413,816 Cash 2022: € 413,816 First fiscal year in the series	€ 494,884 Cash 2023: € 494,884 ▲ 20% vs 2022 (€ 413,816) Favourable step	€ 211,946 Cash 2024: € 211,946 ▼ 57% vs 2023 (€ 494,884) Unfavourable step	€ 863,530 Cash 2025: € 863,530 ▲ € 651,584 vs 2024 (€ 211,946) Favourable step	▲ € 651,584
Retained profit	€ 536,307 Retained profit 2022: € 536,307 First fiscal year in the series	€ 725,639 Retained profit 2023: € 725,639 ▲ 35% vs 2022 (€ 536,307) Favourable step	€ 942,426 Retained profit 2024: € 942,426 ▲ 30% vs 2023 (€ 725,639) Favourable step	€ 1,020,733 Retained profit 2025: € 1,020,733 ▲ 8% vs 2024 (€ 942,426) Favourable step	▲ 8%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 30,000 Dividend 2023: € 30,000 Unchanged (€ 0) Unchanged	€ 90,000 Dividend 2024: € 90,000 ▲ 200% vs 2023 (€ 30,000) Unchanged	€ 175,000 Dividend 2025: € 175,000 ▲ 94% vs 2024 (€ 90,000) Unchanged	▲ 94%
Bank debt	€ 41,270 Bank debt 2022: € 41,270 First fiscal year in the series	€ 41,270 Bank debt 2023: € 41,270 Unchanged (€ 41,270) Unchanged	€ 41,415 Bank debt 2024: € 41,415 Unchanged (€ 41,270) Unfavourable step	€ 41,270 Bank debt 2025: € 41,270 Unchanged (€ 41,415) Favourable step
Balance sheet total	€ 624,382 Balance sheet total 2022: € 624,382 First fiscal year in the series	€ 849,797 Balance sheet total 2023: € 849,797 ▲ 36% vs 2022 (€ 624,382) Unchanged	€ 1,164,886 Balance sheet total 2024: € 1,164,886 ▲ 37% vs 2023 (€ 849,797) Unchanged	€ 1,339,730 Balance sheet total 2025: € 1,339,730 ▲ 15% vs 2024 (€ 1,164,886) Unchanged	▲ 15%

Key figures of Dokter J.SONCK Cardiologie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dokter J.SONCK Cardiologie?

What happened at Dokter J.SONCK Cardiologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 30, 2026 New annual accounts for financial year 2025: profit of € 253,307 (▼ 17% vs 2024). filed late Source: NBB ↗
Nov 21, 2001 New establishment in Asse. KBO
Nov 6, 2001 Start of the company according to the CBE. KBO

In short

From € 73,922 profit in 2022 to € 253,307 profit in 2025.

Paid € 404,829 in corporate taxes since 2022.

Best year ever: 2024, with € 306,787 profit.

Paid out € 295,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dokter J.SONCK Cardiologie? We notify you, reason included.

Follow Dokter J.SONCK Cardiologie

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Jeroen Sonck

Dokter J.SONCK Cardiologie

Hartcentrum Aalst 25%

Behind Dokter J.SONCK Cardiologie is Jeroen Sonck. It owns 25% of Hartcentrum Aalst itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Jeroen Sonck

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Leeuwerikenlaan 10

1780 Wemmel

2.095.360.247

Potteel 12

1730 Asse

Active since 21 November 2001

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ARTERIAX

€ 539,161 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0476.008.692
VAT number: BE 0476.008.692
Registered office: Leeuwerikenlaan 10, 1780 Wemmel
Names & denominations: Dokter J.SONCK Cardiologie
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 November 2001
Peppol: Active · Active since 28 Feb 2024
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗